Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Schizophrenia Research

• Publication date

  2016-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.schres.2016.07.010PMID 27449251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of oxidative stress and mitochondrial/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes

  2016cited by this paper
• Implications for reactive oxygen species in schizophrenia pathogenesis.

  2016cited by this paper
• Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models.

  2016cited by this paper
• Nitroxides protect against peroxynitrite-induced nitration and oxidation.

  2015cited by this paper
• Neuroprotection of posttreatment with risperidone, an atypical antipsychotic drug, in rat and gerbil models of ischemic stroke and the maintenance of antioxidants in a gerbil model of ischemic stroke

  2014cited by this paper
• Does clozapine induce myocarditis, myocardial oxidative stress and DNA damage in rats?

  2014cited by this paper
• Lipid Peroxidation in Psychiatric Illness: Overview of Clinical Evidence

  2014cited by this paper
• How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo.

  2014cited by this paper
• Comparison of the antioxidant potential of antiparkinsonian drugs in different in vitro models

  2014cited by this paper
• The impact of clozapine on regulation of inflammation in murine macrophage cells.

  2014cited by this paper
• Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.

  2012cited by this paper
• Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia.

  2011cited by this paper
• The role of serotonin receptors in the action of atypical antipsychotic drugs.

  2011cited by this paper
• Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells.

  2011cited by this paper
• Schizophrenia: Redox Regulation and Volume Neurotransmission

  2011cited by this paper
• Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.

  2010cited by this paper
• Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases

  2010cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010cited by this paper
• Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation.

  2009cited by this paper
• Potential Effect of Olanzapine on Total Antioxidant Status and Lipid Peroxidation in Schizophrenic Patients

  2009cited by this paper
• Antipsychotic Drugs Inhibit the Human Corticotropin-Releasing-Hormone Gene Promoter Activity in Neuro-2A Cells—an Involvement of Protein Kinases

  2006cited by this paper
• On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies.

  2005cited by this paper
• Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy

  2003cited by this paper
• Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.

  2003cited by this paper
• Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide

  2003cited by this paper
• Total antioxidant capacity.

  2003cited by this paper
• Effect of antidepressant drugs on the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells.

  2002cited by this paper
• Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma

  2002cited by this paper
• Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

  2001cited by this paper
• Biochemical effects of chlorpromazine on mouse neuroblastoma cells.

  1999cited by this paper
• A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes.

  1998cited by this paper
• Antioxidant properties of clozapine and related neuroleptics.

  1998cited by this paper
• Metabolism of clozapine by human neutrophils: evidence for a specific oxidation of clozapine by the myeloperoxidase system with inhibition of enzymatic chlorination cycle

  1997cited by this paper
• The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.

  1996cited by this paper
• A practical method for preparing peroxynitrite solutions of low ionic strength and free of hydrogen peroxide.

  1995cited by this paper
• Isolation of microtubule protein from cultured mouse neuroblastoma cells.

  1970cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• Prevalence and multidimensional impact of sarcopenia in schizophrenia: Associations with oxidative stress, functioning, and symptom severity.

  2026cites this paper
• Persistent oxidative stress and functional outcomes in early psychosis: A longitudinal study.

  2025cites this paper
• Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy.

  2025cites this paper
• Clozapine-N-oxide protects dopaminergic neurons against rotenone-induced neurotoxicity by preventing ferritinophagy-mediated ferroptosis.

  2024cites this paper
• Effects of piperine–haloperidol mixture on ketamine induced schizophrenia rats and metabolism-mediated inhibitory potency: in-vivo and in-vitro evaluation

  2024cites this paper
• CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings

  2024cites this paper
• Alpha Lipoic Acid for Schizophrenia: Future Investigations With Low Doses and Treatment-Resistant Patients-Reply to Letter by Kishi and Colleagues.

  2023cites this paper
• Clozapine suppresses NADPH oxidase activation, counteracts cytosolic H2O2, and triggers early onset mitochondrial dysfunction during adipogenesis of human liposarcoma SW872 cells

  2023cites this paper
• Aripiprazole attenuates the medial prefrontal cortex morphological and biochemical alterations in rats with neonatal ventral hippocampus lesion.

  2023cites this paper
• Apocynin-Tandospirone Derivatives Suppress Methamphetamine-Induced Hyperlocomotion in Rats with Neonatal Exposure to Dizocilpine

  2022cites this paper
• Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia.

  2022cites this paper
• The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer’s Disease

  2022cites this paper
• Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis.

  2022cites this paper
• Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis.

  2021cites this paper
• The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication in Glioblastoma Cell.

  2021cites this paper
• Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives

  2021cites this paper
• Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients

  2021cites this paper
• Involvement of anti-inflammatory, antioxidant, and BDNF up-regulating properties in the antipsychotic-like effect of the essential oil of Alpinia zerumbet in mice: a comparative study with olanzapine

  2021cites this paper
• Antioxidant Status in Paranoid Schizophrenia and Alzheimer’s Disease

  2021cites this paper
• Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?

  2021cites this paper
• Metabolic and behavioral effects of olanzapine and fluoxetine on the model organism Caenorhabditis elegans

  2021cites this paper
• Apocynin-tandospirone derivatives demonstrate antioxidant properties in the animal model of schizophrenia

  2021cites this paper
• NDT_A_283395 555..565

  2021cites this paper
• Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study

  2021cites this paper
• Serum Metabolomic Profiling Based on Fourier Transform-Ion Cyclotron Resonance-Mass Spectrometry: Do the Dysfunctions of Metabolic Pathways Reveal a Universal Risk of Oxidative Stress in Schizophrenia?

  2020cites this paper
• Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia

  2020cites this paper
• Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design

  2020influential citation
• [Antioxidant status in patients with paranoid schizophrenia and Alzheimer disease].

  2020cites this paper
• Exploring the Dendritic Spine Pathology in a Schizophrenia-related Neurodevelopmental Animal Model.

  2019cites this paper
• Radioprotective effect of olanzapine as an anti-psychotic drug against genotoxicity and apoptosis induced by ionizing radiation on human lymphocytes

  2019cites this paper
• Antipsychotic drugs scavenge radiation-induced hydroxyl radicals and intracellular ROS formation, and protect apoptosis in human lymphoma U937 cells

  2019cites this paper
• Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

  2019cites this paper
• Effects of Antipsychotic Treatment on S100B and Oxidative Stress in Patients with Schizophrenia

  2019cites this paper
• Protective effects of Spinacia oleracea seeds extract in an experimental model of schizophrenia: Possible behavior, biochemical, neurochemical and cellular alterations.

  2018cites this paper
• Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients

  2018cites this paper
• Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission

  2018cites this paper
• Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma

  2018cites this paper
• The preclinical discovery and development of paliperidone for the treatment of schizophrenia

  2018cites this paper
• Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.

  2018cites this paper
• Olanzapine alleviates oxidative stress in the liver of socially isolated rats.

  2017cites this paper
• Investigation of the synergistic effects of haloperidol combined with Calculus Bovis Sativus in treating MK-801-induced schizophrenia in rats

  2017cites this paper
• The antidepressant‐ and anxiolytic‐like effects of fluoxetine and clozapine in chronically isolated rats involve inhibition of hippocampal TNF‐&agr;

  2017cites this paper
• Investigation of the synergistic effects of haloperidol combined with 4 Calculus Bovis Sativus in treating MK-801-induced schizophrenia in 5 rats

  2017cites this paper
• Transcriptome Analysis of Systems Biology for Schizophrenia

  2016cites this paper